TY - JOUR
T1 - Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community
T2 - Progress, gaps, and future directions
AU - Taweh, Noor
AU - Schlossberg, Esther
AU - Frank, Cynthia
AU - Nijhawan, Ank
AU - Kuo, Irene
AU - Knight, Kevin
AU - Springer, Sandra A.
N1 - Funding Information:
This research was funded by the National Institute on Drug Abuse ( U01DA053039 , Springer, Knight, Nijhawan), and for career development by the National Institute on Drug Abuse ( K02 DA032322 ) for Springer. The funders were not involved in the research design, analysis or interpretation of the data or the decision to publish the manuscript.
Publisher Copyright:
© 2021
PY - 2021/10
Y1 - 2021/10
N2 - Improving HIV and Hepatitis C Virus (HCV) management among people involved in the criminal justice (CJ) system who use drugs, in particular those with opioid use disorder (OUD), requires effective approaches to screening, linkage, and adherence to integrated prevention and treatment services across correctional and community agencies and providers. This manuscript reviews the literature to explore gaps in HIV, Hepatitis C, and OUD prevention, treatment, and delivery cascades of care for persons involved in the CJ system. Specifically, we compare two models of linkage to prevention and treatment services: Peer/Patient Navigation (PN) wherein the PN links CJ-involved individuals to community-based infectious disease (ID) and substance use prevention and treatment services, and Mobile Health Units (MHU) wherein individuals are linked to a MHU within their community that provides integrated ID and substance use prevention and treatment services. The most notable finding is a gap in the literature, with few to no comparisons of models linking individuals recently released from the CJ system to integrated HIV, Hepatitis C, and OUD prevention and treatment and other harm reduction services. Further, few published studies address the geographical distinctions that affect service implementation and their effects on these substance use, ID and harm reduction care cascades. This manuscript makes specific recommendations to fill this gap through a detailed evaluation of PN and MHU linkage models to co-located and integrated HIV, Hepatitis C, and OUD prevention and treatment services across different communities within the U.S.
AB - Improving HIV and Hepatitis C Virus (HCV) management among people involved in the criminal justice (CJ) system who use drugs, in particular those with opioid use disorder (OUD), requires effective approaches to screening, linkage, and adherence to integrated prevention and treatment services across correctional and community agencies and providers. This manuscript reviews the literature to explore gaps in HIV, Hepatitis C, and OUD prevention, treatment, and delivery cascades of care for persons involved in the CJ system. Specifically, we compare two models of linkage to prevention and treatment services: Peer/Patient Navigation (PN) wherein the PN links CJ-involved individuals to community-based infectious disease (ID) and substance use prevention and treatment services, and Mobile Health Units (MHU) wherein individuals are linked to a MHU within their community that provides integrated ID and substance use prevention and treatment services. The most notable finding is a gap in the literature, with few to no comparisons of models linking individuals recently released from the CJ system to integrated HIV, Hepatitis C, and OUD prevention and treatment and other harm reduction services. Further, few published studies address the geographical distinctions that affect service implementation and their effects on these substance use, ID and harm reduction care cascades. This manuscript makes specific recommendations to fill this gap through a detailed evaluation of PN and MHU linkage models to co-located and integrated HIV, Hepatitis C, and OUD prevention and treatment services across different communities within the U.S.
KW - HIV
KW - Hepatitis C
KW - Medication for opioid use disorder
KW - Mobile Health Unit
KW - Opioid use disorder
KW - Patient/Peer Navigation
UR - http://www.scopus.com/inward/record.url?scp=85107055445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107055445&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2021.103283
DO - 10.1016/j.drugpo.2021.103283
M3 - Article
C2 - 34020864
AN - SCOPUS:85107055445
SN - 0955-3959
VL - 96
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
M1 - 103283
ER -